Branched-chain amino acids are required for the survival and virulence of Actinobacillus pleuropneumoniae in swine.
In Actinobacillus pleuropneumoniae, which causes porcine pleuropneumonia, ilvI was identified as an in vivo-induced (ivi) gene and encodes the enzyme acetohydroxyacid synthase (AHAS) required for branched-chain amino acid (BCAA) biosynthesis. ilvI and 7 of 32 additional ivi promoters were upregulated in vitro when grown in chemically defined medium (CDM) lacking BCAA. Based on these observations, we hypothesized that BCAA would be found at limiting concentrations in pulmonary secretions and that A. pleuropneumoniae mutants unable to synthesize BCAA would be attenuated in a porcine infection model. Quantitation of free amino acids in porcine pulmonary epithelial lining fluid showed concentrations of BCAA ranging from 8 to 30 micromol/liter, which is 10 to 17% of the concentration in plasma. The expression of both ilvI and lrp, a global regulator that is required for ilvI expression, was strongly upregulated in CDM containing concentrations of BCAA similar to those found in pulmonary secretions. Deletion-disruption mutants of ilvI and lrp were both auxotrophic for BCAA in CDM and attenuated compared to wild-type A. pleuropneumoniae in competitive index experiments in a pig infection model. Wild-type A. pleuropneumoniae grew in CDM+BCAA but not in CDM-BCAA in the presence of sulfonylurea AHAS inhibitors. These results clearly demonstrate that BCAA availability is limited in the lungs and support the hypothesis that A. pleuropneumoniae, and potentially other pulmonary pathogens, uses limitation of BCAA as a cue to regulate the expression of genes required for survival and virulence. These results further suggest a potential role for AHAS inhibitors as antimicrobial agents against pulmonary pathogens.
Subashchandrabose
Sargurunathan
S
Comparative Medicine and Integrative Biology Program, Department of Microbiology and Molecular Genetics, 5193 BPS Building, Michigan State University, East Lansing, MI 48824, USA.
LeVeque
Rhiannon M
RM
Wagner
Trevor K
TK
Kirkwood
Roy N
RN
Kiupel
Matti
M
Mulks
Martha H
MH
D000095:Acetolactate Synthase / Q000235:genetics / Q000378:metabolism; D000189:Actinobacillus Infections / Q000235:genetics / Q000378:metabolism*; D016977:Actinobacillus pleuropneumoniae / Q000472:pathogenicity* / Q000502:physiology*; D000597:Amino Acids, Branched-Chain / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism*; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry / Q000382:microbiology; D015964:Gene Expression Regulation, Bacterial; D051756:Leucine-Responsive Regulatory Protein / Q000235:genetics / Q000378:metabolism; D009154:Mutation; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013552:Swine; D015854:Up-Regulation; D014774:Virulence
D000597:Amino Acids, Branched-Chain; D001426:Bacterial Proteins; D051756:Leucine-Responsive Regulatory Protein; C080946:IlvI protein, Bacteria; D000095:Acetolactate Synthase
Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19462-7
19052235
Infect Immun. 2007 Jan;75(1):91-103
17060463
Microbes Infect. 2002 Feb;4(2):225-35
11880056
J Immunol. 1994 Sep 1;153(5):2110-21
8051416
Gene. 1987;57(2-3):239-46
3319780
Microbes Infect. 2001 Nov-Dec;3(14-15):1345-52
11755424
PLoS One. 2008 Jan 16;3(1):e1450
18197260
Gene. 1995 Nov 7;165(1):61-6
7489917
Nat Med. 2000 Nov;6(11):1269-73
11062540
Curr Microbiol. 1997 Sep;35(3):139-44
9236294
J Antimicrob Chemother. 1998 Oct;42(4):475-82
9818746
Microb Pathog. 1999 Nov;27(5):311-27
10545257
J Biol Chem. 2000 Feb 4;275(5):3192-200
10652304
Infect Immun. 1999 Oct;67(10):4983-7
10496867
Mol Microbiol. 1994 Oct;14(2):207-16
7830567
J Bacteriol. 2008 Jan;190(2):602-12
17981960
Int J Antimicrob Agents. 2008 Jun;31(6):567-71
18337064
FEMS Microbiol Lett. 2000 Oct 1;191(1):109-13
11004407
BMC Microbiol. 2008 Apr 11;8:60
18405378
Trends Microbiol. 1995 Jul;3(7):257-61
7551637
Infect Immun. 2000 Mar;68(3):1164-70
10678921
Can J Vet Res. 1994 Apr;58(2):83-6
8004545
Gene. 1985;33(1):103-19
2985470
Curr Opin Microbiol. 2007 Apr;10(2):125-33
17395525
Infect Immun. 1995 Jan;63(1):27-37
7806365
Mol Microbiol. 2003 Apr;48(2):287-94
12675791
FEMS Immunol Med Microbiol. 2006 Nov;48(2):192-204
16995880
Microb Pathog. 2000 Jul;29(1):25-38
10873488
Gene. 1982 Oct;19(3):259-68
6295879
J Appl Physiol (1985). 1986 Feb;60(2):532-8
3512509
Curr Opin Microbiol. 2007 Apr;10(2):182-8
17383223
Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10434-9
8816818
J Bacteriol. 1988 Jun;170(6):2575-83
2836362
Amino Acids. 2006 Sep;31(2):173-210
16699828
Vet Microbiol. 1995 Aug;45(4):383-91
7483251
J Bacteriol. 2009 Feb;191(4):1278-92
19074398
Antimicrob Agents Chemother. 2005 Sep;49(9):3922-5
16127072
Vet Microbiol. 2005 Dec 20;111(3-4):231-6
16271834
Vet Microbiol. 1997 Nov;58(2-4):239-49
9453134
Mol Microbiol. 2007 May;64(4):953-67
17501920
Cell Microbiol. 2007 May;9(5):1311-23
17223926
Gene. 1995 Jul 4;160(1):81-6
7628722
Vet Q. 1989 Apr;11(2):65-72
2525834
Am Rev Respir Dis. 1983 Aug;128(2):266-70
6881688
Annu Rev Microbiol. 1995;49:747-75
8561478
Infect Immun. 1996 Nov;64(11):4659-64
8890222
Infect Immun. 2002 Dec;70(12):6871-9
12438364
Am J Vet Res. 1986 Jul;47(7):1433-41
3740612
Microbiology (Reading). 2002 Jul;148(Pt 7):2191-2201
12101306
FEMS Microbiol Lett. 2000 Aug 1;189(1):15-8
10913859
Microbes Infect. 2004 Mar;6(3):290-8
15026016
Infect Immun. 1998 Jul;66(7):3326-36
9632602
Microbiol Rev. 1994 Sep;58(3):466-90
7968922
J Bacteriol. 1994 Sep;176(18):5665-72
7916011
FEMS Microbiol Lett. 1996 Sep 15;143(1):1-6
8807793
Mol Microbiol. 1997 Oct;26(2):399-407
9383163
Fed Proc. 1958 Dec;17(4):1107-15
13619781
Infect Immun. 1996 Sep;64(9):3905-7
8751947
J Bacteriol. 2008 Feb;190(4):1495-6
18065534
Infect Immun. 1996 Oct;64(10):4154-62
8926083